Literature DB >> 30919341

PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.

Liwei Lang1, Ron Chemmalakuzhy2, Chloe Shay3,4, Yong Teng5,6,7.   

Abstract

Phosphofructokinase-1 (PFK-1), a rate-determining enzyme of glycolysis, is an allosteric enzyme that regulates the oxidation of glucose in cellular respiration. Glycolysis phosphofructokinase platelet (PFKP) is the platelet isoform and works as an important mediator of cell metabolism. Considering that PFKP is a crucial player in many steps of cancer initiation and metastasis, we reviewed the specificities and complexities of PFKP and its biological roles in human diseases, especially malignant tumors. The possible use of PFKP as a diagnostic marker or a drug target in the prevention or treatment of cancer is also discussed.

Entities:  

Keywords:  Biologic roles; Cancer; Diagnostic marker; Drug target; Gene regulations; PFKP

Mesh:

Substances:

Year:  2019        PMID: 30919341     DOI: 10.1007/978-3-030-12668-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  12 in total

1.  Astragalus polysaccharide mitigates transport stress-induced hepatic metabolic stress via improving hepatic glucolipid metabolism in chicks.

Authors:  Bi-Chen Zhao; Yi-Xi Tang; Bai-Hao Qiu; Hao-Liang Xu; Tian-Hao Wang; Ahmed Ibrahim Ahmed Elsherbeni; Hassan Bayoumi Ali Gharib; Jin-Long Li
Journal:  J Anim Sci       Date:  2022-09-01       Impact factor: 3.338

2.  Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis.

Authors:  Pengfei Liu; Weidong Tian
Journal:  PeerJ       Date:  2020-08-03       Impact factor: 2.984

3.  Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts.

Authors:  Ran Wei; Robert M Hackman; Yuefei Wang; Gerardo G Mackenzie
Journal:  Cancers (Basel)       Date:  2019-10-05       Impact factor: 6.639

4.  Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer.

Authors:  Rui Ma; Yinsheng Wu; Shanshan Li; Xilan Yu
Journal:  Front Cell Dev Biol       Date:  2021-04-27

5.  Bacillus toyonensis SAU-19 Ameliorates Hepatic Insulin Resistance in High-Fat Diet/Streptozocin-Induced Diabetic Mice.

Authors:  Samuel Kumi Okyere; Lei Xie; Juan Wen; Yinan Ran; Zhihua Ren; Junliang Deng; Yanchun Hu
Journal:  Nutrients       Date:  2021-12-17       Impact factor: 5.717

6.  PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.

Authors:  Zongwei Zhang; Wei Liang; Qiang Luo; Hongtu Hu; Keju Yang; Jijia Hu; Zhaowei Chen; Jili Zhu; Jun Feng; Zijing Zhu; Qingjia Chi; Guohua Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-14       Impact factor: 5.555

7.  Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.

Authors:  Liwei Lang; Fang Wang; Zhichun Ding; Xiangdong Zhao; Reid Loveless; Jin Xie; Chloe Shay; Peng Qiu; Yonggang Ke; Nabil F Saba; Yong Teng
Journal:  J Exp Clin Cancer Res       Date:  2021-12-14

8.  Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.

Authors:  Xingwei Lu; Xingguang Liu
Journal:  J Healthc Eng       Date:  2022-04-07       Impact factor: 3.822

Review 9.  Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis.

Authors:  Marisol Miranda-Galvis; Yong Teng
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 10.  Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer.

Authors:  Shangwei Zhong; Shoujiao Peng; Zihua Chen; Zhikang Chen; Jun-Li Luo
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.